Inari is poised to enhance Stryker's footprint ... The company’s portfolio of mechanical thrombectomy devices is set to ‘complement’ Stryker’s neurovascular division.

Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.7, marking a significant milestone for the ...

Inari Medical stock skyrocketed Monday afternoon and again Tuesday morning after a report that it was close to being acquired by Stryker proved to be true, with the companies announcing the deal after ...

Charles R. Goulding and Preeti Sulibhavi examine how Stryker's acquisition of Inari Medical is set to transform vascular care ...

Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

4. Zimmer Biomet has entered into a definitive agreement to purchase Paragon 28, a medical device company focused exclusively on foot-and-ankle orthopedics.

Inari shareholders are getting a fair price ... stents, and mechanical thrombectomy devices. It’s a business that Stryker has built through a combination of internal R&D and M&A, including ...